Total Payments
$1,056
2024 Payments
$815.81
Companies
17
Transactions
49
Medicare Patients
165
Medicare Billing
$14,152
Payment Breakdown by Category
Food & Beverage$1,056 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,056 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $209.65 | 3 | $0 (2024) |
| ABBVIE INC. | $189.99 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $153.46 | 9 | $0 (2024) |
| PFIZER INC. | $97.18 | 5 | $0 (2024) |
| LivaNova USA, Inc. | $62.73 | 3 | $0 (2024) |
| UCB, Inc. | $44.27 | 2 | $0 (2023) |
| Lilly USA, LLC | $43.14 | 3 | $0 (2024) |
| ARGENX US, INC. | $43.06 | 2 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $39.72 | 2 | $0 (2024) |
| Lundbeck LLC | $36.81 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $815.81 | 41 | ABBVIE INC. ($189.99) |
| 2023 | $240.09 | 8 | Biogen, Inc. ($96.31) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Neurology | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Neurology | ||||||
| 09/18/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $98.50 | General |
| Category: Neurology | ||||||
| 09/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.74 | General |
| Category: NEUROLOGY | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: Neurology | ||||||
| 08/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Neurology | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Neuroscience | ||||||
| 08/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Neurology | ||||||
| 07/31/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Neurology | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: PAIN | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: Neurology | ||||||
| 06/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: PAIN | ||||||
| 06/11/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Neurology | ||||||
| 06/03/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Neurology | ||||||
| 05/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 165 | 205 | $164,047 | $14,152 |
Total Patients
165
Total Services
205
Medicare Billing
$14,152
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 71 | $23,359 | $4,373 | 18.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 31 | $19,344 | $3,147 | 16.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 18 | $16,074 | $2,431 | 15.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 27 | 27 | $42,336 | $1,158 | 2.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 12 | $5,652 | $1,112 | 19.7% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 17 | 18 | $31,626 | $776.52 | 2.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 16 | 16 | $23,520 | $686.40 | 2.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 12 | $2,136 | $467.40 | 21.9% |
About Dr. Samuel Capouch, MD
Dr. Samuel Capouch, MD is a Neurology healthcare provider based in Springfield, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2019. The National Provider Identifier (NPI) number assigned to this provider is 1326501750.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Capouch, MD has received a total of $1,056 in payments from pharmaceutical and medical device companies, with $815.81 received in 2024. These payments were reported across 49 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,056).
As a Medicare-enrolled provider, Capouch has provided services to 165 Medicare beneficiaries, totaling 205 services with total Medicare billing of $14,152. Data is available for 1 year (2023–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Springfield, IL
- Active Since 04/11/2019
- Last Updated 11/21/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1326501750
Products in Payments
- KESIMPTA (Drug) $146.06
- UBRELVY (Drug) $131.32
- TYSABRI (Biological) $111.15
- VUMERITY (Drug) $98.50
- NURTEC ODT (Drug) $97.18
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $62.73
- QULIPTA (Drug) $58.67
- VYVGART (Drug) $43.06
- INGREZZA (Drug) $39.72
- VYEPTI (Biological) $36.81
- EMGALITY (Drug) $28.50
- BRIUMVI (Drug) $23.97
- INBRIJA (Drug) $21.39
- Gamunex-C (Biological) $20.90
- INFINITY (Device) $19.85
- MAVENCLAD (Drug) $18.65
- Hizentra (Biological) $18.01
- AMYVID (Drug) $14.64
- Ocrevus (Biological) $13.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Springfield
David Clark, Do, DO
Neurology — Payments: $1.1M
Neurology $1.1M
Raymond Englander, Md, MD
Neurology — Payments: $167,481
Neurology $167,481
Dr. Jenifer Zhai, Md, MD
Neurology — Payments: $121,314
Neurology $121,314
Cecile Becker, M.d, M.D
Neurology — Payments: $78,042
Neurology $78,042
Jennifer Lynch, Md, MD
Neurology — Payments: $73,454
Neurology $73,454
Jayant Acharya, Md, MD
Neurology — Payments: $56,046
Neurology $56,046